Desarrollo del escap-cdv como instrumento de medida para la valoración de la calidad de vida en el cáncer de próstata. primera parte

Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments

“…Four instruments were designed for all tumor stages (Estudio sobre la Calidad de Vida en el Cáncer de Próstata—ESCAP-CDV [31], EORTC QLQ-PR25 [32], FACT-P [33], and Patient-Oriented Prostate Utility Scale—PORPUS [34]) and the other four were developed specifically for patients at early-stage disease (Expanded Prostate Cancer Index Composite—EPIC [35], Prostate Cancer Quality of Life Instrument—PC-QoL [36], Prostate Cancer Symptom Indices—PCSI [37] and UCLA-PCI [38]). The EORTC QLQ-PR25 [32] and FACT-P [33] are tumor location-specific modules and were developed to complement the corresponding cancer-specific core questionnaire that measures general well-being (EORTC QLQ-C30 and FACT-General, respectively).…”

“…The EORTC QLQ-PR25 [32] and FACT-P [33] are tumor location-specific modules and were developed to complement the corresponding cancer-specific core questionnaire that measures general well-being (EORTC QLQ-C30 and FACT-General, respectively). The ESCAP-CDV [31] is a Spanish instrument which covers eight dimensions of general health and one prostate cancer-specific module. The PORPUS [34] is a unidimensional utility instrument composed by five general health and five prostate cancer-specific questions.…”

“…of items)BowelSexualUrinaryOther1. ESCAP-CDVMorales et al [31]2To design a prostate cancer-specific QoL instrument valid in Spanish population, based on the EORTC QLQ-C3All stagesFour-point Likert’s (lower scores mean better QoL)Last 4 weeks34 (10′)9–––Eight general health domains (30)One prostate cancer-specific domain (6)2. EORTC QLQ-PR25Van Andel et al [32]5 (3)To assess treatment-related complications of prostate cancer therapyAll stagesFour-point Likert’s; 0–100 b Last 1–4 weeks25 (15′)6B.…”